154 related articles for article (PubMed ID: 20013809)
1. Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1.
Ng KT; Lee TK; Cheng Q; Wo JY; Sun CK; Guo DY; Lim ZX; Lo CM; Poon RT; Fan ST; Man K
Int J Cancer; 2010 Aug; 127(4):859-72. PubMed ID: 20013809
[TBL] [Abstract][Full Text] [Related]
2. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma.
He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L
Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma.
Lee NP; Tsang FH; Shek FH; Mao M; Dai H; Zhang C; Dong S; Guan XY; Poon RT; Luk JM
Int J Cancer; 2010 Aug; 127(4):968-76. PubMed ID: 19998337
[TBL] [Abstract][Full Text] [Related]
6. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.
Rong Y; Chen H; Zhou XF; Yin CQ; Wang BC; Peng CW; Liu SP; Wang FB
Oncotarget; 2016 Feb; 7(7):8282-94. PubMed ID: 26882565
[TBL] [Abstract][Full Text] [Related]
7. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma.
Ng KT; Man K; Sun CK; Lee TK; Poon RT; Lo CM; Fan ST
Br J Cancer; 2006 Oct; 95(8):1050-5. PubMed ID: 17008870
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
10. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
[TBL] [Abstract][Full Text] [Related]
13. Tiam1 is associated with hepatocellular carcinoma metastasis.
Huang J; Ye X; Guan J; Chen B; Li Q; Zheng X; Liu L; Wang S; Ding Y; Ding Y; Chen L
Int J Cancer; 2013 Jan; 132(1):90-100. PubMed ID: 22573407
[TBL] [Abstract][Full Text] [Related]
14. HDAC5 promotes cell proliferation in human hepatocellular carcinoma by up-regulating Six1 expression.
Feng GW; Dong LD; Shang WJ; Pang XL; Li JF; Liu L; Wang Y
Eur Rev Med Pharmacol Sci; 2014; 18(6):811-6. PubMed ID: 24706304
[TBL] [Abstract][Full Text] [Related]
15. The HOX gene network in hepatocellular carcinoma.
Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
[TBL] [Abstract][Full Text] [Related]
16. A decade's studies on metastasis of hepatocellular carcinoma.
Tang ZY; Ye SL; Liu YK; Qin LX; Sun HC; Ye QH; Wang L; Zhou J; Qiu SJ; Li Y; Ji XN; Liu H; Xia JL; Wu ZQ; Fan J; Ma ZC; Zhou XD; Lin ZY; Liu KD
J Cancer Res Clin Oncol; 2004 Apr; 130(4):187-96. PubMed ID: 14685850
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
Shen B; Chu ES; Zhao G; Man K; Wu CW; Cheng JT; Li G; Nie Y; Lo CM; Teoh N; Farrell GC; Sung JJ; Yu J
Br J Cancer; 2012 Apr; 106(9):1486-94. PubMed ID: 22472882
[TBL] [Abstract][Full Text] [Related]
19. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules.
Kuriyama S; Hitomi M; Yoshiji H; Nonomura T; Tsujimoto T; Mitoro A; Akahane T; Ogawa M; Nakai S; Deguchi A; Masaki T; Uchida N
Int J Oncol; 2005 Aug; 27(2):505-11. PubMed ID: 16010434
[TBL] [Abstract][Full Text] [Related]
20. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
